Summary of Proceedings of the 40th Annual General Meeting of the Companyheld on Friday, August 8, 2025
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SeQuent Scientific Limited held its 40th Annual General Meeting on Friday, August 8, 2025, from 4:00 PM to 4:21 PM via video conferencing. The meeting was chaired by Independent Director Dr. Kamal Sharma, with MD & CEO Mr. Rajaram Narayanan, CFO Mr. Saurav Bhala, and other board members present; only one director, Mr. Neeraj Bharadwaj, was unable to attend. Nine resolutions were put to vote through remote e-voting and e-voting during the meeting, with results to be announced within statutory timelines. Key items included adoption of FY25 audited financial statements, re-appointment of two Independent Directors (Dr. Kamal Sharma and Mr. Milind Sarwate) for a second 5-year term starting August 25, 2025, appointment of a new Secretarial Auditor for five years, and approval of remuneration for the MD & CEO and Non-Executive Directors.
This is a routine regulatory filing summarising the AGM proceedings — no immediate stock price impact is expected, but the proposed re-appointments and remuneration approvals indicate board continuity. Shareholders should watch for the e-voting results, which will be filed separately with the stock exchanges within the regulatory deadline.